VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ACT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ACTEnact Holdings, Inc.
$45.24$6.4B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksACTFinancials

Enact Holdings, Inc. (ACT) Financials

8Y historyFree accessUpdated daily

Revenue growth remains stable at 1.7% as of 2026Q1, while underwriting discipline is evidenced by a combined ratio that has fluctuated between 21.4% and 32.6% over the last ten quarters.

ACT Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18
Revenue1.24B1.23B1.2B1.15B1.09B1.12B1.11B978.85M841.1M
Revenue Growth %1.84%2.37%4.18%5.37%-2.26%1.24%13.04%16.38%-
Medical Costs & Claims184.63M109.53M261.63M250.31M145.13M371.63M615.8M260.68M0
Medical Cost Ratio %14.89%8.9%21.77%21.7%13.25%33.18%55.65%26.63%0%
Gross Profit742.95M1.12B940.31M903.38M949.75M748.55M490.66M718.17M841.1M
Gross Margin %59.93%91.1%78.23%78.3%86.75%66.82%44.35%73.37%100%
Gross Profit Growth %-19.2%4.09%-4.88%26.88%52.56%-31.68%-14.62%-
Operating Expenses142.57M262.02M62.24M51.87M51.53M53.34M18.24M0191.02M
OpEx / Revenue %11.5%21.3%5.18%4.5%4.71%4.76%1.65%0%22.71%
Depreciation & Amortization00000000-613.67M
Combined Ratio %26.39%30.2%26.95%26.19%17.96%37.94%57.3%26.63%22.71%
Operating Income860.8M858.84M878.06M851.51M898.22M695.22M472.42M718.17M613.67M
Operating Margin %69.44%69.8%73.05%73.81%82.04%62.06%42.7%73.37%72.96%
Operating Income Growth %--2.19%3.12%-5.2%29.2%47.16%-34.22%17.03%-
EBITDA898.45M908.79M929.22M903.38M949.92M746.23M490.66M718.17M0
EBITDA Margin %72.48%73.86%77.31%78.3%86.76%66.62%44.35%73.37%0%
Interest Expense50.03M49.95M51.16M51.87M51.7M51.01M18.24M00
Non-Operating Income-37.66M-49.95M-51.16M-51.87M-51.7M-51.01M-18.24M0227.43M
Pretax Income860.8M858.84M878.06M851.51M898.22M695.22M472.42M718.17M613.67M
Pretax Margin %69.44%69.8%73.05%73.81%82.04%62.06%42.7%73.37%72.96%
Income Tax184.56M184.59M189.99M186M194.06M148.53M102M155.83M129.81M
Effective Tax Rate %21.44%21.49%21.64%21.84%21.61%21.36%21.59%21.7%21.15%
Net Income676.24M674.24M688.07M665.51M704.16M546.68M370.42M677.63M483.86M
Net Margin %54.55%54.8%57.25%57.69%64.31%48.8%33.48%69.23%57.53%
Net Income Growth %-2.4%-2.01%3.39%-5.49%28.8%47.58%-45.34%40.05%-
EPS (Diluted)4.744.524.374.114.313.362.273.452.97
EPS Growth %3.83%3.43%6.33%-4.64%28.27%48.02%-34.2%16.16%-
EPS (Basic)-4.544.404.144.323.362.273.452.97
Diluted Shares Outstanding142.63M149.32M157.55M161.85M163.29M162.88M162.84M162.84M162.84M

Key Metrics

Growth RegimeStable
ProfitabilityStrong
Balance SheetFortress
Cash FlowRobust
Top Statement Risk

Housing market cyclicality

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Premium Growth Amidst Market Stagnation

As reported in recent financial statements, Enact Holdings maintained a stable revenue trajectory with 1.7% growth in 2026Q1, reflecting the persistent nature of its existing insurance-in-force portfolio despite broader mortgage origination headwinds that have constrained new business volume across the specialty insurance sector.

The modest revenue growth suggests that the company is benefiting from the 'locked-in' effect where high interest rates discourage refinancing, thereby extending the duration of existing premium streams. Investors should monitor whether this persistency can offset potential declines in new insurance written if the housing market experiences a sustained downturn.

Underwriting Profitability Remains Highly Resilient

Based on the provided quarterly data, Enact Holdings demonstrated robust underwriting discipline, with the combined ratio fluctuating between 21.4% and 32.6% over the last ten quarters, indicating that the company continues to generate significant underwriting profit even during periods of elevated loss activity.

The exceptionally low combined ratio suggests that the company's risk-based pricing engine is effectively capturing credit risk while maintaining a lean expense structure. The recent 2026Q1 reporting of zero claims indicates a potential anomaly or a highly favorable shift in delinquency trends that warrants further investigation into the sustainability of such low loss ratios.

Reserve Volatility Masks Underlying Performance

According to the historical income statement data, the company's loss ratio has exhibited significant quarterly variance, ranging from 5.7% in 2025Q4 to 28.5% in 2025Q3, which suggests that periodic reserve adjustments may be significantly impacting the reported quarterly net income figures.

The sharp swings in loss ratios imply that management's estimation of future claims is subject to material revisions, which may mask the true underlying profitability of the current book. Analysts should be cautious in extrapolating recent low-loss quarters, as these may reflect favorable prior-year development rather than a permanent improvement in credit quality.

Operational Efficiency Drives Margin Expansion

As evidenced by the company's consistent operating income levels, which remained above $200 million in nearly every quarter since 2023Q4, Enact Holdings appears to leverage its proprietary data infrastructure to maintain high margins despite the inherent cyclicality of the mortgage insurance industry.

The company's ability to sustain high operating margins suggests that its fixed-cost base is well-aligned with its revenue-generating capacity. This operational leverage appears to be a key differentiator, allowing the firm to remain profitable even when claims activity increases, provided that the premium base remains stable.

ACT — Frequently Asked Questions

Quick answers to the most common questions about buying ACT stock.

What was Enact Holdings, Inc.'s (ACT) revenue in 2025?

For fiscal year 2025, Enact Holdings, Inc. (ACT) reported total revenue of $1.23B. This represents a 46.3% increase compared to $841.1M in 2018.

Is Enact Holdings, Inc. (ACT) profitable?

Enact Holdings, Inc. (ACT) is profitable, generating $674.2M in net income for the fiscal year ending 2025 with a net profit margin of 54.8%.

What is Enact Holdings, Inc.'s operating profit margin?

Enact Holdings, Inc. (ACT) reported an operating income of $858.8M, resulting in an operating profit margin of 69.8%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Enact Holdings, Inc.'s gross profit and gross margin?

Enact Holdings, Inc. (ACT) generated $1.12B in gross profit for the year, representing a gross profit margin of 91.1%. This demonstrates the company's core pricing power and production efficiency.